Literature DB >> 1085282

Secondary cytotoxic cell response to lymphocytic choriomeningitis virus II. Nature and specificity of effector cells.

M B Dunlop, P C Doherty, R M Zinkernagel, R V Blanden.   

Abstract

The method described in the previous paper was used to induce secondary responses in spleen cells from CBA/H mice, pre-primed with lymphocytic choriomeningitis (LCM) virus by culturing them with LCM-infected peritoneal cells. The cytolytic effector cells thus generated have been characterized. Effector cells were sensitive to treatment with anti-theta ascitic fluid and complement. Separation procedures based on rosetting of certain categories of lymphocytes with sheep red cells through an Isopaque-Ficoll gradient indicated that effector cells lacked surface immunoglobulin and generally did not bear Fc receptors. Cytolytic activity was restricted by the H-2 gene complex. Killing had single-hit characteristics. All these results suggested that the cells from memory cultures mediating cytolysis were T cells. There was evidence for two T cell subsets, a major subpopulation directed against antigens on infected targets and a minor one directed against antigens on uninfected, H-2-compatible targets. Specificity was present at the infected cell:memory responder and killer:target levels between LCM virus (an arenavirus) and ectromelia virus (a poxvirus).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085282      PMCID: PMC1445118     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  An anti-theta sensitive hapten-carrier response in nude mice.

Authors:  S M Kirov
Journal:  Eur J Immunol       Date:  1974-11       Impact factor: 5.532

2.  Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis.

Authors:  P C Doherty; R M Zinkernagel; I A Ramshaw
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

3.  Characteristics of the interaction in vitro between cytotoxic thymus-derived lymphocytes and target monolayers infected with lymphocytic choriomeningitis virus.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

4.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

5.  Quantitative analysis of the 51Cr release cytotoxicity assay for cytotoxic lymphocytes.

Authors:  R G Miller; M Dunkley
Journal:  Cell Immunol       Date:  1974-11       Impact factor: 4.868

6.  Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics.

Authors:  I Gardner; N A Bowern; R V Blanden
Journal:  Eur J Immunol       Date:  1974-02       Impact factor: 5.532

7.  Cell-medicated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex.

Authors:  I D Gardner; N A Bowern; R V Blanden
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

8.  Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.

Authors:  U Koszinowski; R Thomssen
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

9.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets.

Authors:  E D Johnson; G A Cole
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

View more
  9 in total

1.  Cytotoxic T cells specific for influenza virus-infected target cells.

Authors:  K L Yap; G L Ada
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

2.  Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. III. In vivo protective activity of effector cells generated in vitro.

Authors:  M B Dunlop
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

3.  Cytotoxic T cell response to lymphocytic choriomeningitis virus. Properties of precursors of effector T cells, primary effector T cells and memory T cells in vitro and in vivo.

Authors:  M B Dunlop; P C Doherty; R M Zinkernagel; R V Blanden
Journal:  Immunology       Date:  1977-09       Impact factor: 7.397

4.  Immunological properties of Fc receptor on lymphocytes. VIII. The behaviour of FcR+ and FcR- T cells in cell-mediated immune responses.

Authors:  A Takabayashi; T Masuda; S Suzuki; M Hanaoka
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397

5.  Fragment Bb of bovine complement factor B: stimulatory effect on the microbicidal activity of bovine monocytes.

Authors:  M S Sethi; H Tabel
Journal:  Can J Vet Res       Date:  1990-10       Impact factor: 1.310

6.  Blockade of gammac signals in combination with donor-specific transfusion induces cardiac allograft acceptance in murine models.

Authors:  Sheng Chang; Li Wang; Xingguang Lin; Fuli Xiang; Bicheng Chen; Zhonghua Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

7.  Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction.

Authors:  R M Welsh
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

8.  Mechanisms of suppression of cytotoxic T-cell responses in murine lymphocytic choriomeningitis virus infection.

Authors:  M B Dunlop; R V Blanden
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

9.  Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.

Authors:  S Oehen; H Waldner; T M Kündig; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.